SLC16A1 and hepatocellular carcinoma: Inhibition of hydroxycarboxylic acid receptor 1 (HCAR1) or monocarboxylate transporter 1 (MCT1) blocks lactate uptake and reduces ATP production in hepatocellular carcinoma cells, resulting in the activation of AMPK signaling and ferroptosis.164